| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.6B | $8.8B | $9.4B | $9.4B | $7.2B | $1.7B | $1.5B | $6.0B |
| Cost of Revenue | $7.0B | $6.8B | $7.3B | $7.6B | $6.1B | $5.5B | $5.1B | $5.1B |
| Gross Profit | — | — | — | — | — | $0.3B | $0.3B | $0.2B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.7B | $0.8B | $0.8B | $0.8B | $0.5B | $0.5B | $0.5B | $0.5B |
| Operating Income | $0.8B | $1.1B | $1.2B | $0.9B | $0.4B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.4B | $0.7B | $0.7B | $0.5B | $0.2B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $1.48 | $2.16 | $2.35 | $1.69 | $0.69 | $0.24 | $0.11 | $0.16 |
| EPS (Diluted) | $1.48 | $2.16 | $2.34 | $1.69 | $0.68 | $0.24 | $0.11 | $0.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.8B | $11.1B | $11.2B | $10.3B | $10.5B | $7.8B | $7.3B | $7.1B |
| Current Assets | $2.9B | $2.8B | $2.8B | $2.7B | $2.5B | $2.0B | $1.8B | $1.8B |
| Cash & Equivalents | $0.3B | $0.2B | $0.2B | $0.1B | $0.2B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.2B | $1.9B | $2.6B | $1.9B | $2.0B | $1.9B | $1.2B | $1.2B |
| Stockholders' Equity | $3.3B | $3.0B | $2.8B | $2.1B | $1.9B | $1.4B | $1.6B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.8B | $1.1B | $1.1B | $0.6B | $0.8B | $0.7B | $-0.4B |
| Investing Cash Flow | $-0.7B | $-0.3B | $-1.0B | $-0.4B | $-2.4B | $-0.6B | $-0.2B | $0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.0B | $-0.5B | $-0.1B | $-0.7B | $1.8B | $-0.2B | $-0.4B | $-0.3B |